SAINTE-FOY, QUEBEC--(Marketwire - April 01, 2008) - Bioxel Pharma Inc. (TSX VENTURE: BIP), a leading manufacturer of taxane active pharmaceutical ingredients (APIs), is pleased to announce that it has received two consecutive reports on patentability from the International Examining Authority that confirm the strength of the Corporation’s docetaxel patent applications.
